ctrl K

Watchlist Price Alert

Neumora Therapeutics Inc.... (NMRA)

NASDAQ: NMRA · Real-Time Price · USD

0.82

-0.04 (-5.05%)

At close: Jun 17, 2025, 10:45 AM

Neumora Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	142.15M	374.04M	240.94M	409.25M	191.98M	n/a
Short-Term Investments	165.43M	79.94M	130.94M	n/a	n/a	n/a
Long-Term Investments	n/a	9.85M	23.51M	n/a	n/a	n/a
Other Long-Term Assets	n/a	1.21M	4.13M	9.65M	183K	n/a
Receivables	n/a	939K	919K	200K	148K	n/a
Inventory	n/a	n/a	50K	125K	n/a	n/a
Other Current Assets	6.48M	n/a	50K	125K	125K	n/a
Total Current Assets	314.06M	478.28M	387.95M	415.6M	193.84M	n/a
Property-Plant & Equipment	2.92M	6.86M	10.64M	4.04M	3.92M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.92M	17.92M	38.28M	13.69M	4.11M	n/a
Total Assets	316.97M	496.19M	426.23M	429.3M	197.95M	n/a
Account Payables	3.31M	337K	7.15M	1.64M	2.4M	n/a
Deferred Revenue	n/a	n/a	11.54M	19.1M	5.6M	n/a
Short-Term Debt	1.85M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	24.73M	10.15M	10.04M	8.13M	4.13M	n/a
Total Current Liabilities	29.89M	25.11M	23.7M	23.28M	9.37M	21K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	22K	155K	844.32M	730.24M	281.68M	n/a
Total Long-Term Liabilities	22K	2.01M	849.39M	731.24M	282.96M	n/a
Total Liabilities	29.91M	27.12M	873.08M	754.52M	292.33M	21K
Total Debt	1.85M	5.23M	8.44M	2.05M	2.04M	n/a
Common Stock	16K	16K	16K	14K	13K	n/a
Retained Earnings	-947.22M	-703.43M	-467.51M	-336.61M	-99.29M	-21K
Comprehensive Income	62K	-76K	-774K	-729.86M	n/a	n/a
Shareholders Equity	287.06M	469.08M	-446.85M	-325.22M	-94.38M	-21K
Total Investments	165.43M	89.79M	154.45M	n/a	n/a	n/a